Renaissance Technologies’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-13,921
| Closed | -$16K | – | 4307 |
|
2023
Q3 | $16K | Sell |
13,921
-3,345
| -19% | -$3.85K | ﹤0.01% | 3551 |
|
2023
Q2 | $23K | Buy |
17,266
+6,241
| +57% | +$8.31K | ﹤0.01% | 3753 |
|
2023
Q1 | $12K | Buy |
11,025
+900
| +9% | +$980 | ﹤0.01% | 3878 |
|
2022
Q4 | $24K | Sell |
10,125
-17,600
| -63% | -$41.7K | ﹤0.01% | 3940 |
|
2022
Q3 | $119K | Buy |
+27,725
| New | +$119K | ﹤0.01% | 3537 |
|
2022
Q2 | – | Sell |
-3,172
| Closed | -$27K | – | 4726 |
|
2022
Q1 | $27K | Buy |
3,172
+1,916
| +153% | +$16.3K | ﹤0.01% | 3985 |
|
2021
Q4 | $14K | Buy |
+1,256
| New | +$14K | ﹤0.01% | 3853 |
|
2021
Q3 | – | Sell |
-21,207
| Closed | -$394K | – | 4054 |
|
2021
Q2 | $394K | Buy |
21,207
+4,600
| +28% | +$85.5K | ﹤0.01% | 3060 |
|
2021
Q1 | $413K | Buy |
16,607
+12,148
| +272% | +$302K | ﹤0.01% | 2981 |
|
2020
Q4 | $90K | Buy |
+4,459
| New | +$90K | ﹤0.01% | 3264 |
|
2020
Q3 | – | Sell |
-3,729
| Closed | -$147K | – | 3865 |
|
2020
Q2 | $147K | Buy |
3,729
+1,874
| +101% | +$73.9K | ﹤0.01% | 3216 |
|
2020
Q1 | $78K | Buy |
1,855
+873
| +89% | +$36.7K | ﹤0.01% | 3269 |
|
2019
Q4 | $166K | Buy |
982
+340
| +53% | +$57.5K | ﹤0.01% | 3229 |
|
2019
Q3 | $241K | Buy |
642
+59
| +10% | +$22.1K | ﹤0.01% | 3093 |
|
2019
Q2 | $324K | Buy |
583
+75
| +15% | +$41.7K | ﹤0.01% | 3150 |
|
2019
Q1 | $591K | Buy |
508
+25
| +5% | +$29.1K | ﹤0.01% | 2873 |
|
2018
Q4 | $547K | Buy |
483
+167
| +53% | +$189K | ﹤0.01% | 2830 |
|
2018
Q3 | $478K | Buy |
316
+150
| +90% | +$227K | ﹤0.01% | 2860 |
|
2018
Q2 | $211K | Buy |
166
+157
| +1,744% | +$200K | ﹤0.01% | 3063 |
|
2018
Q1 | $86K | Buy |
+9
| New | +$86K | ﹤0.01% | 3273 |
|
2016
Q2 | – | Sell |
-2
| Closed | -$221K | – | 3641 |
|
2016
Q1 | $221K | Buy |
+2
| New | +$221K | ﹤0.01% | 3053 |
|